MAGDALENA DAWSON: Open Payments
NPI 1235610031 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$576 in 30 payments from 14 companies in 2025. Trend: 2023 $647 · 2024 $1,575 · 2025 $576
Food & beverage: $576
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 2 | $148 |
| Fresenius USA Marketing, Inc. | 4 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $64 |
| Otsuka America Pharmaceutical, Inc. | 3 | $44 |
| OPKO Pharmaceuticals, LLC | 2 | $38 |
| ANI Pharmaceuticals, Inc. | 2 | $36 |
| AKEBIA THERAPEUTICS INC | 2 | $32 |
| Travere Therapeutics, Inc. | 5 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
Products named: TARPEYO, VELPHORO, Kerendia, JYNARQUE, RAYALDEE, PURIFIED CORTROPHIN GEL, Vafseo, Vanrafia.
Industry payments across IA — which companies pay providers there.
